Obesity and cortisol

被引:440
作者
Björntorp, P
Rosmond, P
机构
[1] Gothenburg Univ, Sahlgrens Hosp, Dept Heart & Lung Dis, S-41345 Gothenburg, Sweden
[2] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
关键词
obesity; cortisol; sympathetic nervous system; sex steroid hormones; growth hormone; perinatal factors;
D O I
10.1016/S0899-9007(00)00422-6
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Cortisol in obesity is a much-studied problem. Previous information indicates that cortisol secretion is elevated but that circulatory concentrations are normal or low, suggesting that peripheral disappearance rate is elevated. These studies have usually not taken into account the difference between central and peripheral types of obesity. Recent studies using saliva cortisol have indicated that the problem is complex with both high and low secretion of cortisol, perhaps depending on the status of the function of the hypothalamic-pituitary-adrenal gland axis. A significant background factor seems to be environmental stress. The results also suggest that the pattern of cortisol secretion may be important. Other neuroendocrine pathways are also involved, including the central sympathetic nervous system, the gonadal and growth hormone axes, and the leptin system. In concert, these abnormalities seem to be responsible for the abnormal metabolism often seen in central obesity. Several associated polymorphisms of candidate genes may provide a genetic background. Cortisol conversion to inactive metabolites may be a factor increasing central signals to secretion and may add to the increased secretion of cortisol induced by centrally acting factors. Perinatal factors have been found to be involved in the pathogenesis of obesity and its complications. The mechanism involved is not known, but available information suggests that programming of the hypothalamic-pituitary-adrenal axis may be responsible. Nutrition 2000;16:924-936. (C) Elsevier Science Inc. 2000.
引用
收藏
页码:924 / 936
页数:13
相关论文
共 118 条
  • [111] CARBENOXOLONE INCREASES HEPATIC INSULIN SENSITIVITY IN MAN - A NOVEL ROLE FOR 11-OXOSTEROID REDUCTASE IN ENHANCING GLUCOCORTICOID RECEPTOR ACTIVATION
    WALKER, BR
    CONNACHER, AA
    LINDSAY, RM
    WEBB, DJ
    EDWARDS, CRW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (11) : 3155 - 3159
  • [112] 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN VASCULAR SMOOTH-MUSCLE AND HEART - IMPLICATIONS FOR CARDIOVASCULAR-RESPONSES TO GLUCOCORTICOIDS
    WALKER, BR
    YAU, JL
    BRETT, LP
    SECKL, JR
    MONDER, C
    WILLIAMS, BC
    EDWARDS, CRW
    [J]. ENDOCRINOLOGY, 1991, 129 (06) : 3305 - 3312
  • [113] ABNORMALITIES OF GLUCOCORTICOID METABOLISM AND THE RENIN-ANGIOTENSIN SYSTEM - A 4-CORNERS APPROACH TO THE IDENTIFICATION OF GENETIC-DETERMINANTS OF BLOOD-PRESSURE
    WATT, GCM
    HARRAP, SB
    FOY, CJW
    HOLTON, DW
    EDWARDS, HV
    DAVIDSON, HR
    CONNOR, JM
    LEVER, AF
    FRASER, R
    [J]. JOURNAL OF HYPERTENSION, 1992, 10 (05) : 473 - 482
  • [114] AN ASSOCIATION BETWEEN A BC1I-RESTRICTION FRAGMENT LENGTH POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR LOCUS AND HYPERINSULINEMIA IN OBESE WOMEN
    WEAVER, JU
    HITMAN, GA
    KOPELMAN, PG
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1992, 9 (03) : 295 - 300
  • [115] THE INFLUENCE OF WEIGHT-LOSS ON THE DEXAMETHASONE SUPPRESSION TEST
    YEREVANIAN, BI
    BACIEWICZ, GJ
    IKER, HP
    PRIVITERA, MR
    [J]. PSYCHIATRY RESEARCH, 1984, 12 (02) : 155 - 160
  • [116] Zahrzewska KE, 1997, DIABETES, V46, P717
  • [117] BETA-ENDORPHIN AND ADRENOCORTICAL FUNCTION IN OBESITY
    ZELISSEN, PMJ
    KOPPESCHAAR, HPF
    ERKELENS, DW
    THIJSSEN, JHH
    [J]. CLINICAL ENDOCRINOLOGY, 1991, 35 (04) : 369 - 372
  • [118] ZIMMERMAN M, 1984, BIOL PSYCHIAT, V19, P923